During the past decade, Oncology Department of The First Affiliated Hospital of Zhengzhou University conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Department of The First Affiliated Hospital of Zhengzhou University" #1 collaborator was "Zhengzhou University" with 3 trials as a collaborator, "Cancer Hospital of Guizhou Province" with 2 trials as a collaborator, "Qingdao University" with 2 trials as a collaborator, "Second Hospital of Shanxi Medical University" with 2 trials as a collaborator and "Shanxi Province Cancer Hospital" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Department of The First Affiliated Hospital of Zhengzhou University" are "Diffuse Large B Cell Lymphoma" (4 trials), "Nasal and Nasal-type NK/T-cell Lymphoma" (2 trials), "Peripheral T-cell Lymphoma" (2 trials), "Primary CNS Lymphoma (PCNSL)" (2 trials) and "Primary Central Nervous System Lymphoma" (2 trials). Many other conditions were trialed in "Oncology Department of The First Affiliated Hospital of Zhengzhou University" in a lesser frequency.

Most popular intervention types in "Oncology Department of The First Affiliated Hospital of Zhengzhou University" are "Drug" (18 trials), "Combination Product" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apatinib" (2 trials), "CHOP regimen" (2 trials), "DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)" (2 trials), "Decitabine" (2 trials) and "HD-MTX-Ara-C regimen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Department of The First Affiliated Hospital of Zhengzhou University" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Oncology Department of The First Affiliated Hospital of Zhengzhou University". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Oncology Department of The First Affiliated Hospital of Zhengzhou University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Department of The First Affiliated Hospital of Zhengzhou University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 0 trials that are defined as “Not Applicable".